Form 8-K - Current report:
SEC Accession No. 0001558370-24-008951
Filing Date
2024-06-06
Accepted
2024-06-06 16:05:11
Documents
15
Period of Report
2024-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrns-20240606x8k.htm   iXBRL 8-K 53556
2 EX-10.1 mrns-20240606xex10d1.htm EX-10.1 1186568
3 EX-10.2 mrns-20240606xex10d2.htm EX-10.2 42656
  Complete submission text file 0001558370-24-008951.txt   1624360

Data Files

Seq Description Document Type Size
4 EX-101.SCH mrns-20240606.xsd EX-101.SCH 3250
5 EX-101.LAB mrns-20240606_lab.xml EX-101.LAB 16588
6 EX-101.PRE mrns-20240606_pre.xml EX-101.PRE 10710
18 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20240606x8k_htm.xml XML 5013
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 241025008
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)